ADOT - BIOMODA: Profitable Technology with Purpose Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Popiye who wrote (829)	4/25/1998 11:04:00 PM
From: Mark Haythorn	of 4650

I think Brad's assessment is right on the money. Just keep in mind that Biomoda's technology is 'young' in that we have a LONG way to go before seeing any money from a therapeutic agent, if it even works. The diagnostic could be much faster. So, keep the Biomoda deal in perspective- it is a start-up biotech venture with lots of risk. Considering the stock is abt. 20 cents per share, I think it's a great risk! In my opinion, don't bet the farm on ADOT, but there certainly is upside potential. Heck, the stock saw 50 cents just a few weeks ago (200+% more than it is now) -Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next